Lupin Limited (NSE:LUPIN)
India · Delayed Price · Currency is INR 2,125.00
+42.00 (2.02%)
Sep 21, 2026, 3:15 PM IST
Lupin Market Cap
Lupin has a market cap or net worth of 969.34 billion as of September 21, 2026. Its market cap has increased by 3.21% in one year.
Market Cap
969.34B
Enterprise Value
957.20B
Revenue
299.67B
Ranking
n/a
PE Ratio
17.53
Stock Price
2,125.00
ChartMarket Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 969.34B, an increase of 97,014.60%. That is a compound annual growth rate of 29.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 969.34B | 0.47% |
| Dec 31, 2025 | 964.76B | -10.05% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.50T |
| Zydus Lifesciences | 1.16T |
| Cipla | 1.13T |
| Laurus Labs | 1.06T |
| Mankind Pharma | 1.01T |
| Aurobindo Pharma | 997.71B |
| Glenmark Pharmaceuticals | 690.66B |
| Alkem Laboratories | 653.60B |